return to press releases

January 16, 2002

John Hotchkiss Joins AnVil Informatics as Chief Technology Officer

Lowell, MA - AnVil Informatics, Inc., a provider of in silico drug discovery services, has announced the appointment of John Hotchkiss to Chief Technology Officer. Hotchkiss brings an extensive background in managing technology for the life sciences, Internet, engineering, and consumer computing industries.

"We are pleased to have someone with John's breadth and depth of technical experience on our team," said Dr. Richard Gill, President and Chief Executive Officer of AnVil Informatics. "AnVil provides discovery solutions and partnerships to life sciences and drug discovery companies. It is key that we have strong technical leadership to maintain our focus on making commercially important discoveries, working side-by-side with scientists, applying our expertise in biology, chemistry, analysis and high-dimensional visualization to their data."

Prior to joining AnVil, Mr. Hotchkiss was Chief Technology Officer at ActiveCyte, Inc., and Vice President, Global Engineering at Terra Lycos (previously Lycos, Inc.). He also served in technology and engineering management positions at Harlequin, Inc., Apple Computer's Advanced Technology Group, Symbolics, Inc., Lisp Machines, Inc., and Itek Optical Systems.

Hotchkiss manages AnVil's highly experienced team of scientists, informatics and data visualization specialists, and data miners who are expert at navigating large, high dimensional data sets. He reports to Dr. Richard Gill and is responsible for all science and technology development, including data mining activities and commercial development of AnVil's technology platform.

Mr. Hotchkiss received his B.A. cum laude from Harvard University.

About AnVil Informatics

AnVil Informatics, Inc. works in partnership with leading life science, pharmaceutical and biotechnology companies to provide in silico drug discovery services and other integrated solutions that typically include a mix of professional services and custom software tools. AnVil's unique expertise in the application of both analytic and visual methods enables the extraction of a maximum amount of knowledge from the complex data sets involved in the drug discovery process, thereby enhancing every step in the client's decision making process; generating informed decisions faster and more accurately. Additional information can be found at http://www.anvilinfo.com/

Copyright © 2002 AnVil, Inc. All rights reserved.

back to top